Clene Inc. (NASDAQ: CLNN) Receives FDA Guidance On Accelerated Approval Pathway For CNM-Au8(R) For ALS
The FDA asked for additional Neurofilament Light (“NfL”) data from the company's three Expanded Access Protocols to support earlier ...